Jan van der Auwera

Uteron Pharma SA is engaged in the research and development of controlled release devices. The firms products Levosert and Diafert provide pharmaceutical solutions for women's health. The company was founded by Stijn van Rompay in 2010 and is headquartered in Grâce-Hollogne, Belgium.

Docpharma NV provides generic drugs. These drugs are used to treat infections, hypertension, allergies, bronchial and asthmatic problems, gastric and vomiting discomforts, pain and depression. It was founded by Leon Van Rompay in 1999 and is headquartered in Heverlee, Belgium.

Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY.

UCB Pharma SA discovers and develops biopharmaceutical products. It is a biopharmaceutical company focuses on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. The company is headquartered in Brussels, Belgium.

Part of Chemical Works of Gedeon Richter Plc, Neuralis SA is a Belgian company that engages in research and experimental development on biotechnology. The company is based in Liege, Belgium. The CEOs are Christophe Maréchal, Xavier Paoli. The company was founded in 2013.

Belgische federatie van de chemische industrie en van life, also known as essenscia, is a Belgian company based in Brussels, Belgium. The company represents the interests of Belgian companies operating in the chemical, pharmaceutical, and biotech industries. Yves Verschueren has been the CEO of the private company since 2007.

The Shift operates as an association.

Vlaamse Instelling Voor Technologisch Onderzoek NV provides customer research services. The company provides its services to the energy suppliers, appliance builders, end users and government sectors. The company was founded in 1991 and is headquartered in Mol, Belgium.

Founded in 1999, KBC Securities USA, Inc. is a broker/dealer located in New York City. The firm began as the Financial Products group of D. E. Shaw & Co. In 1999, they were purchased by KBC Bank NV. They are a subsidiary of KBC Securities USA, Inc. and their ultimate parent is of KBC Groupe SA (LSE: KBC). KBC Securities is a specialist in annuities, convertible bonds and equity derivatives with a strategic focus on technology. They serve a range of global investors including mutual funds, pension funds, insurance companies, banks, private banks and hedge funds.

Fordham University provides college and university. It offers undergraduate colleges and graduate & professional schools. The company was founded in 1841 and is headquartered in Bronx, NY.

Part of InQpharm Group, Neem Biotech Ltd. is a British biotech company focused on developing groundbreaking ways of defeating big health challenges. The company is based in St. Mellons, UK. Leveraging their unique position in antimicrobial R&D, they have expertise in drug discovery. Neem Biotech was acquired by InQpharm Group on August 09, 2012.

F2G Ltd. provides novel drugs for the treatment of life-threatening systemic fungal diseases. It primarily focuses on developing an F3 series of anti mould compound, which is an antifungal agent that acts through a mechanism different from marketed drugs. The company was founded in 1998 and is headquartered in Manchester, the United Kingdom.

Part of AstraZeneca PLC, Zeneca Garden Care is a British company that develops and manufactures pharmaceutical products, agrochemicals, and specialty chemicals. The company is based in Macclesfield, UK. Zeneca Garden Care was acquired by Zeneca Group Plc on January 01, 1995 for $84.16 million.

Zaluvida Holdings Pte Ltd. provides solutions that improve the lives of livestock and protect the planet. Zaluvida Holdings is based in Singapore, Singapore. The Singaporean company also offers products that help pets stay healthier. The private company's focus is on developing new alternatives to antibiotics that can benefit farmers. and has subsidiaries in Switzerland, Germany, and Malaysia.

HepaRegeniX GmbH engages in the development of treatment for acute and chronic liver diseases. It focuses on Mitogen-Activated Protein Kinase 4, which unlocks the regenerative capacity of hepatocytes even in severely diseased livers. The company was founded in by Wolfgang Albrecht in 2017 and is headquartered in Tuebingen, Germany.

InteRNA Technologies BV develops RNA technologies and applications. It provides drug discovery and development services for the treatment of cancer based on the proprietary microRNA (miRNA) functions. The company develops miRNA-based therapeutics that control genes connected in signal transduction pathways and biological processes as a part of cancer initiation, progression and metastasis. InteRNA Technologies was founded by Edwin Cuppen and Eugene Berezikov in December 2006 and is headquartered in Nijmegen, the Netherlands.

Apaxen SA is a privately-held biotechnology company that was founded in 2018 and is based in an undisclosed location. The Belgian company has raised €5.4 million in equity and grant funding since its A round in 2019. Apaxen is focused on developing a pipeline of NLRP3 inflammasome inhibitors with a novel mechanism of action for the treatment of chronic inflammatory and autoimmune diseases. The company's clinical candidate, MFC-1040, is an orally bioavailable and selective small molecule NLRP3 inflammasome inhibitor that has demonstrated efficacy in multiple animal models of chronic inflammatory disease and pulmonary fibrosis. The company's team combines the experience required for clinical development of its products and is supported by a world-class team of scientific advisors. Apaxen has a pipeline of products at discovery and preclinical stages of development for the treatment of diseases associated with chronic inflammation that depend on NLRP3 inflammasome activation. The company was founded in 2018 by Gael Jalce, Enrico Jose Adolfo Bastianelli, and Bart Wuurman has been the CEO of the company since 2020.

Novalon SA manufactures pharmaceutical products. It focuses on the development of therapeutically equivalent generic products that are complex to develop and manufacture. The firm develops the projects Zoreline and Myring, which are therapeutic equivalents to branded products. The company is headquartered in Liege, Belgium.

Part of AbbVie, Inc., Odyssea Pharma SPRL is a pharmaceutical development and Belgian production company. The company is based in Grâce-Hollogne, Belgium.

Part of Laboratoires S.M.B. SA, SMB Technology is a Belgian company that provides IT consulting services. The company is based in Brussels, Belgium. The CEO of the company is Caroline Baudier.

AuXin Surgery SA develops, manufactures, and supplies combined medical devices for non-invasive surgery. The private company is based in Ottignies-Louvain-la-Neuve, Belgium. The Belgian company was founded in 2014 by Philippe Capart, Cecile Capart, Herve Capart, Carlo Zini, and Gilles Capart. The CEO is Benoît Verjans.

Hedera 22 SCRL supplies and leases computers and office equipment. The company was founded by Sébastien Rigali, Pierre Tocquin, Marc Hanikenne and Denis Baurain on May 25, 2015 and is headquartered in Esneux, Belgium.